Physician profile
Eric B Sandy
NPI 1710951827
$743.75
in general payments reported to CMS, 2019-2025
16 companies · $102 in 2025
The $102 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $80.34 · 2021: $118 · 2022: $127 · 2023: $41.22 · 2024: $47.74 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $169.73 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $91.91 | 2019 | |
| Abiomed | $63.13 | 2025 | |
| Mylan Specialty L.P. | $60.95 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $57.73 | 2021-2023 | Camzyos |
| Pfizer INC. | $51.96 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $48.88 | 2022 | |
| Novo Nordisk INC | $42.39 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $27.55 | 2024 | |
| Alexion Pharmaceuticals, INC. | $24.76 | 2023 | Soliris |
| Sanofi-Aventis U.S. LLC | $20.63 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.53 | 2025 | |
| Allergan, INC. | $19.49 | 2020 | |
| Inspire Medical Systems, INC. | $17.86 | 2025 | Inspire |
| Boston Scientific Corporation | $13.66 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sandy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.